Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1996-07-31
1999-03-16
Myers, Carla J.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 912, 435 915, 435 9151, 536 2431, 536 2433, 536 235, C12Q 168, C07H 2104, C12P 1934
Patent
active
058828648
ABSTRACT:
Disclosed are diagnostic techniques for the detection of human prostate cancer. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in prostate cancer compared to normal human prostate or benign prostatic hyperplasia.
REFERENCES:
patent: 5262311 (1993-11-01), Pardee et al.
patent: 5633161 (1997-05-01), Shyjan
patent: 5639656 (1997-06-01), Wright, Jr.
patent: 5665547 (1997-09-01), Pardee et al.
Deguchi et al. Cancer Research 53:5350-5354, Nov., 1993.
Garcia-Arenas. et al. Mol. & Cell. Endocrin. 111;29-37, Apr. 28, 1995.
Prashar et al P.N.A.S., USA 93:659-663, Jan., 1996.
Adam et al. Proceedings: American Association for Cancer Research 36:25, Mar., 1995.
Bussemakers et al. Cancer Research 51:606-611, Jan., 1991.
Kawasaki et al. in PCR Technology: Principles and Applications For DNA Amplification, Stockton Press New York, pp. 89-97, 1989.
Badalament et al., "An algorithm for predicting nonorgan confined prosate cancer using the results obtained from sextant core biopsies with prostate specific antigen level," J. Urol., 156:1375-1380, 1996.
Veltri et al., "Ability to predict biochemical progression using gleason score and a computer-generated quantitative nuclear grade derived form cancer cell nuclei," Urology, 48(5):685-691, 1996.
An et al., "Identification of Novel Gene Markers in Prostate Disease by RNA Fingerprinting," Proceedings of the American Association for Cancer Research Annual Meeting, 37(0):248, 1996. Abstract No. 1692.
An et al., "Sensitive, Nonradioactive Differential Display Method Using Chemiluminescent Detection," Biotechniques, 20(3):342, 344, 346, 1996.
Blok et al., "Isolation of cDNAs That Are Differentlially Expressed Between Androgen-dependent and Androgen-independent Prostate Carcinoma Cells Using Differential Display PCR", Prostate, 26(4):213-224, 1995.
Hamdy et al., Circulating prostate Specific Antigen-positive Cells Correlate with Metastatic Prostate Cancer, British Journal of Urology, 69(4):392-396, 1992.
Robson et al., Identificatin of Prostatic Androgen Regulated Genes Using the Differential Display Technique, Proceedings of the American Association for Cancer Research Anual Meetings, 36:266, 1995. Abstract No. 1589.
EMBL. Sequence Data Library, Heidelberg, BRD, XP002019347, Accession No. W67972.
PCT Search Report mailed Mar. 7, 1997.
Alcaraz, Antonio, et al., "Aneuploidy and Aneusomy of Chromosome 7 Detected by fluorescence in Situ Hybridization Are Makers of Poor Prognosis in Prostate Cancer", Cancer Research, 54:3998-4002, Aug. 1994.
An, G., et al., Isolation of Genes differentially expressed in prostate cancer cells with metastatic potential by arbitrarily-primed differential analyses (ADA), Proc. Amer. Assn. Canc. Res., 36:82 (#491), 1995.
Bookstein, Robert, et al. "Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene", Science, 247:712-715, Feb., 1990.
Bookstein, Robert, et al., "Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma", Proc. Natl. Acad. Sci. USA, 87:7762-7766, Oct., 1990.
Bova, G. Steven, et al., "Homozygous Deletion and Frequent Allelic Loss of Chromosome 8p22 Loci in Human Prostate Cancer", Cancer Research, 53:3869-3873, Sep., 1993.
Carter, Bob S., et al., "Allelic loss of chromosomes 16q and 10q in human prostate cancer", Proc. Natl. Acad. Sci. USA, 87:8751-8755, Nov., 1990.
Chen, Michael E., et al., "Androgen-Independent Human Prostate Cancer Progression: The Isolation of Novel Stage-Specific Sequences Using Differential mRNA Display", Proc. Natl. Urol. Assn., 153:267A, 1995.
Donohue, Patrick J., et al., "A Delayed-early Gene Activated by Fibroblast Growth Factor-1 Encodes a Protein Related to Aldose Reductase", The Journal of Biological Chemistry, 269(11):8604-8609, 1994.
Dumont, Francis J., et al., "Relationship Between Multiple Biologic Effects of Rapamycin and the Inhibition of pp70S6 Protein Kinase Activity", Journal of Immunology, 992-1003, 1994.
Isaacs, William B., et al., "Molecular Biology of Prostate Cancer", Seminars in Oncology, 21(5):514-521, Oct., 1994.
Isaacs, William B., et al., "Wild-Type p53 Suppresses Growth of Human Prostate Cancer Cells Containing Mutant p53 Alleles", Cancer Research, 51:4716-4720, Sep., 1991.
Liang, Peng and Pardee, Arthur B., "Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain Reaction", Science, 257:967-971, Aug., 1992.
Liang, Peng, et al., "Differential Display and Cloning of Messenger RNAs from Human Breast Cancer versus Mammary Epithelial Cells", Cancer Research, 52:6966-6968, Dec., 1992.
Macoska, Jill A., et al., "Fluorescence in Situ Hybridization Analysis of 8p Allelic Loss and Chromosome 8 Instability in Human Prostate Cancer", Cancer Research, 54:3824-3830, Jul., 1994.
Mok, Samuel C., et al., "Molecular Cloning of Differentially Expressed Genes in Human Epithelial Ovarian Cancer", Gynecological Oncology, 52:247-252, 1994.
Morton, Donald L., et al., "Multivariate Analysis of the Relationship between Survival and the Microstage of Primary Melanoma by Clark Level and Breslow Thickness", Cancer, 71(11):3737-3743, Jun., 1993.
Morton, Ronald A., et al., "Reduction of E-Cadherin Levels and Deletion of the .alpha.-Catenin Gene in Human Prostate Cancer Cells", Cancer Research, 53:3585-3590, Aug., 1993.
Qiao, Liang, et al., "Effects of Suramin on Expression of Proliferation Associated Nuclear Antigens in DU-145 Prostate Carcinoma Cells", Biochemical and Biophysical Research Communications, 201(2):581-588, Jun., 1994.
Riber, Manuel and Rieber, Mary Strasberg, "Cyclin-dependent Kinase 2 and Cyclin A Interaction with E2F Are Targets for Tyrosine Induction of B16 Melanoma Terminal Differentiation", Cell Growth & Differentiation, 5:1339-1346, Dec., 1994.
Sager, Ruth, et al., "Identification by differential display of alpha-6 integrin as a candidate tumor suppressor gene", Methodology Communications, 7:964-970, Jul., 1993.
Scott, Gary K., et al., "A Truncated Intracellular HER2
eu Receptor Produced by Alternative RNA Processing Affects Growth of Human Carcinoma Cells"Molecular and Cellular Biology, 13(4):2247-2257, Apr., 1993.
Slamon, Dennis J., et al., "Expression of Cellular Oncogenes in Human Malignancies", Science, 224:256-262, Apr., 1984.
Takahashi, Satoru, et al., "Potential Markers of Prostate Cancer Aggressiveness Detected by Fluorescence in Situ Hybridization in Needle Biopsies", Cancer Research, 54:3574-3576, Jul., 1994.
Umbas, Rainy, et al., "Expression of the Cellular Adhesion Molecule E-Cadherin Is Reduced or Absent in High-Grade Prostate Cancer", Cancer Research, 52:5104-5109, Sep., 1992.
Visakorpi, Tapio, et al., "Sensitive Detection of Chromosome Copy Number Abberations in Prostate Cancer by Fluorescence In Situ Hydbridization", Americal Journal of Pathology, 145(3):624-630, Sep., 1994.
Watson, Mark A. and Fleming, Timothy P., "Isolation of Differentially Expressed Sequence tags from Human Breast Cancer", Cancer Research, 54:4598-4602, Sep., 1994.
Webb, Karen S. Gerald H. Lin, "Urinary Fibronectin-Potential as a Biomarker in Prostatic Cancer", Investigative Urology, 17(5)401-404, Mar., 1980.
Welsh, John, et al., "Arbitrarily primed PCR fingerprinting of RNA", Nucleic Acids Research, 20(19):4965-4970, 1990.
Wong, Kwong-Kwok, et al., "Identification of differentially expressed RNA in human ovarian carcinoma cells by arbitrarily primed PCR fingerprinting of total RNAs", Intl J of Onc, 3:13-17, 1993.
An Gang
O'Hara S. Mark
Ralph David
Veltri Robert
Myers Carla J.
Urocor Inc.
LandOfFree
Biomarkers and targets for diagnosis, prognosis and management o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomarkers and targets for diagnosis, prognosis and management o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers and targets for diagnosis, prognosis and management o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-816389